Med-Chemist : "Quintessential Medicinal Chemistry"
Tuesday, January 7, 2020
Selinexor Offers Hope Against a Tough-to-Treat Blood Cancer
›
In continuation of my update on Selinexor Patients with a form of blood cancer known as multiple myeloma who haven't responde...
FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults
›
U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptom...
Sunday, January 5, 2020
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
›
In continuation of my update on Selinexor Karyopharm Therapeutics Inc. an oncology-focused pharmaceutical company, announced that ...
Saturday, January 4, 2020
FDA Approves Thiola EC (tiopronin) for the Treatment of Cystinuria
›
Retrophin, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of Thiola EC (tiopronin)...
Tuesday, December 24, 2019
Ipsen Announces U.S. FDA Approval for Newly Designed Pre-Filled Syringe for Somatuline Depot (lanreotide)
›
Ipsen Biopharmaceuticals, an affiliate of Ipsen , announced today that the United States Food and Drug Administration (FDA) has appr...
Monday, December 23, 2019
Dova Pharmaceuticals Announces FDA Approval of Doptelet (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)
›
In continuation of my update on avatrombopag Dova Pharmaceuticals, Inc. a pharmaceutical company focused on acquiring, developi...
Saturday, December 21, 2019
Experimental Drug, Voxelotor, Shows Early Promise Against Sickle Cell Disease
›
An experimental drug for sickle cell disease reduced anemia and boosted the health of red blood cells in patients, according to a ...
Saturday, November 30, 2019
FDA Approval of Xofluza (baloxavir marboxil) for High Risk of Developing Influenza-Related Complications
›
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug ...
Friday, November 29, 2019
FDA Approves Second Drug, Vyleesi, to Help Women With Low Libido
›
In continuation of my update on bremelanotide The U.S. Food and Drug Administration on Friday gave its approval to Vyleesi, the secon...
Thursday, November 28, 2019
FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia
›
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Admin...
Wednesday, November 27, 2019
FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters
›
UCB announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application for the company’s newest a...
‹
›
Home
View web version